NEW YORK (GenomeWeb News) – A GlaxoSmithKline study suggests variants in the gene coding for the beta-2 adrenergic receptor do not affect an individual’s response to its asthma drugs Advair Diskus (fluticasone propionate and salmeterol inhalation powder) or Serevent Diskus (salmeterol xinofoate inhalation powder), the company announced yesterday at the American Academy of Allergy, Asthma and Immunology annual meeting in Philadelphia.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

What happens to scientific papers when certain journals are no longer published? Some scientists are trying to make sure they don't disappear forever.

A study in Microbiome finds that heavy drinkers have an unhealthy mix of bacteria in their mouths.

Doctors and patients are still trying to figure out what role at-home genetic testing should play in healthcare, Newsweek says.

In Genome Research this week, mismatch repair deficiency in C. elegans, retracing transcriptions start site evolution in the human genome, and more.